Free Trial
→ The most explosive assets in 2025? (From Brownstone Research) (Ad) Buy NBY Stock  Free NBY Stock Alerts

NovaBay Pharmaceuticals (NBY) SEC Filings & 10K Form

NovaBay Pharmaceuticals logo
$0.56 0.00 (-0.58%)
As of 03:57 PM Eastern
Compare

Recent NovaBay Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/15/2025
11:40 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:46 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:50 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:11 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:18 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:22 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:30 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:30 PM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:33 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEF 14A
03/11/2025
3:35 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:07 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:08 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
02/06/2025
5:30 PM		NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:58 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:58 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
01/23/2025
7:12 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
01/23/2025
7:13 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:27 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:06 PM		NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
01/10/2025
6:03 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
6:00 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:12 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
12/09/2024
6:05 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/26/2024
3:08 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/22/2024
3:27 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
7:10 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/13/2024
4:15 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/12/2024
3:52 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/08/2024
4:31 PM		Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
3:46 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:15 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:19 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
10/16/2024
3:27 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:19 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFM14A
09/25/2024
4:17 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form PREM14A
09/20/2024
7:08 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:08 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form DEFA14A
07/29/2024
3:25 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
6:18 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 424B4
07/26/2024
4:19 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form POS EX
07/25/2024
11:15 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form EFFECT
Elon’s 2025 Silver Crisis (What It Means for You) (Ad)

Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.

I'm offering a new 2025 Silver Wealth Guide and it is now available.
07/24/2024
7:49 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1/A
07/12/2024
5:21 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1/A
07/11/2024
7:50 AM		NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
Form FWP
07/11/2024
7:45 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:05 PM		NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
Form FWP
07/10/2024
8:30 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1/A
06/28/2024
3:21 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 424B3
06/28/2024
2:19 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
06/27/2024
11:15 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form EFFECT
06/21/2024
4:26 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/20/2024
4:12 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/14/2024
7:47 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:30 AM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:50 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:43 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K/A
05/30/2024
8:24 PM		NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
WU MIJIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:27 PM		NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Sit Swan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:29 PM		Freiman Paul E. (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:31 PM		Garlikov Julie (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:17 PM		NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Zheng Yongxiang (Reporting)
Zheng Yongxiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
8:22 PM		NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Zheng Yenyou (Reporting)
Zheng Yenyou (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:27 PM		NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:NBY) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
Elon’s 2025 Silver Crisis (What It Means for You)
Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...
GoldenCrest Metals | Sponsored
Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...
The Tomorrow Investor | Sponsored
Trump Quietly Planning $15 Trillion Crypto Shocker
Most investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...
Paradigm Press | Sponsored
Dollar Collapse Warning: Protect Your Wealth NOW
Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...
Lear Capital | Sponsored